Offer extended until 31 July 2026: get a 10% early-bird discount on all events starting on or after 25 August 2026. To the promotion
GMP search engine – look up GMP compliance regulations and news
EU Pharma Package: EMA with single Point of Information
Recommendation
1/2 December 2026
How to implement EU-GMP Chapter 8
On the Road to 30,000 Members
Let us become the World's Leading GMP/GDP Compliance Community in 2026
The European Medicines Agency EMA has created a webpage dedicated to the implementation of the reform of the EU pharmaceutical legislation. This new pharmaceutical legislation represents the most significant overhaul of the regulatory framework in over two decades. It aims to modernise how medicines are developed, authorised, and made available to patients across the EU.
The newly launched webpage will serve as a central repository of information for all EMA's stakeholders, providing up-to-date guidance and resources. It highlights the key benefits of the new pharmaceutical legislation and, once the new legislative text is adopted in 2026, it will offer detailed insights into the implementation process on specific technical and procedural aspects.
The webpage will cover in particular the six activity areas overseen by EMA, namely:
- Centralised procedure and committees
- Development support
- Environmental risks
- Quality and manufacturing
- Shortages
- Regulatory and legal aspects
EMA will provide details on these activity areas following the adoption of the new legislative text in 2026.
Related GMP News
02.11.2026Singapore Added to the List of Recognised third Countries for Importation of APIs
02.11.2026Failed GMP Training in 2026: Further GMP Training Deficiencies in FDA Warning Letters
21.10.2026Switzerland: GMP Compliance by Foreign Manufacturers
14.10.2026EU Pharma Package: Council Adopts New Rules
14.10.2026ICH Publishes New Training Material for Quality Guidelines
14.10.2026WHO issues Draft Guidance on Quality Risk Management